18.03.21|Hezi SternlichtThe Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
19.08.20|Sophie ShulmanBoston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4
26.07.20|CTechIsraeli startup develops machine vision-based technology for blood test analysis and infectious disease diagnosis
05.07.18|CTechThe deal was announced in March, but intended buyer InSight backed out
04.07.18|CTechClal Biotechnology Industries is an Israel-based life sciences investment company